Dietrich Ruess
Principal Investigator
Department of Surgery, General and Visceral Surgery
Medical Center University of Freiburg
Hugstetter Straße 55
79106 Freiburg
- +49 761 270-24010
- dietrich.ruess@uniklinik-freiburg.de
- Homepage
Current position
Board certified Visceral Surgeon, PI ‘Max Eder’ Junior Group (Stiftung Deutsche Krebshilfe)
Academic training
| 2005 - 2011 | Medical School, Eberhard-Karls-Universität Tübingen; Internships in Haifa (ISR), Paris (FRA), New York City (USA) |
Advanced academic qualifications
| 2012 | Doctorate (Dr. med.), Department of Immunology, Eberhard-Karls-Universität Tübingen |
Postgraduate positions
| Since 2020 | ‘Max Eder’ Junior Group, Stiftung Deutsche Krebshilfe (DKH) |
| Since 2018 | Organ retrieval Surgeon, Deutsche Stiftung Organtransplantation (DSO) |
| 2018 - 2020 | Ctd. Residency and Fellowship in General and Visceral Surgery, Department of Surgery, Medical Center University of Freiburg |
| 2015 - 2018 | Postdoctoral Research Fellow at the Laboratory for Gastrointestinal Cancer and Inflammatory Research, Internal Medicine II, Klinikum rechts der Isar, TU München |
| 2011 - 2015 | Residency and Fellowship in General and Visceral Surgery, Department of Surgery, Medical Center University of Freiburg |
Miscellaneous (Honors, Awards)
| 2021 | Full scholarship (medhochzwei Verlag), MBA Health Care Management programme, Campus Akademie Universität Bayreuth |
| 2021 | Admission into the “Exzellenzakademie der Lehrstuhlinhaber Allgemein- und Viszeralchirurgie” |
| 2021 | Berta-Ottenstein Advanced Clinician Scientist programme, Medical Faculty, Albert-Ludwigs Universität Freiburg |
| 2018 | Württembergischer Krebspreis, Dres. Bayer Stiftung |
| 2018 | Travel grant, European Pancreatic Club (EPC) |
| 2017 | Abstract prize, United European Gastroenterology (UEG) |
| 2017 | Fellowship, Mildred-Scheel-Cancer-Conference, Deutsche Krebshilfe |
| 2016 | Abstract prize + oral free paper award, UEG |
| 2015 | Abstract prize, Deutsche Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) |
Publications listed in PubMed®
Publications (based on CRC1479 funding)
Chen X, Keller SJ, Hafner P, Alrawashdeh AY, Avery TY, Norona J, Zhou J, Ruess DA. Tyrosine phosphatase PTPN11/SHP2 in solid tumors – bull’s eye for targeted therapy? Front Immunol. 2024 Mar 5;15:1340726. doi: 10.3389/fimmu.2024.1340726.
Elrakaybi A, Ruess DA, Lübbert M, Quante M, Becker H. Epigenetics in Pancreatic Ductal Adenocarcinoma: Impact on Biology and Utilization in Diagnostics and Treatment. Cancers (Basel). 2022 Nov 30;14(23):5926. doi: 10.3390/cancers14235926.
Avery TY, Köhler N, Zeiser R, Brummer T, Ruess DA. Onco-immunomodulatory properties of pharmacological interference with RAS-RAF-MEK-ERK pathway hyperactivation. Front Oncol. 2022 Jul 27;12:931774. doi: 10.3389/fonc.2022.931774.
Contact
